0001213900-23-072246.txt : 20230830 0001213900-23-072246.hdr.sgml : 20230830 20230830164540 ACCESSION NUMBER: 0001213900-23-072246 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230828 FILED AS OF DATE: 20230830 DATE AS OF CHANGE: 20230830 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jermasek Douglas CENTRAL INDEX KEY: 0001955273 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40582 FILM NUMBER: 231225812 MAIL ADDRESS: STREET 1: 4300 EL CAMINO REAL STREET 2: SUITE 210 CITY: LOS ALTOS STATE: CA ZIP: 94022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Unicycive Therapeutics, Inc. CENTRAL INDEX KEY: 0001766140 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 813638692 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4300 EL CAMINO REAL, SUITE 210 CITY: LOS ALTOS STATE: CA ZIP: 94022 BUSINESS PHONE: 650-384-0642 MAIL ADDRESS: STREET 1: 4300 EL CAMINO REAL, SUITE 210 CITY: LOS ALTOS STATE: CA ZIP: 94022 4 1 ownership.xml X0508 4 2023-08-28 0 0001766140 Unicycive Therapeutics, Inc. UNCY 0001955273 Jermasek Douglas C/O UNICYCIVE THERAPEUTICS LOS ALTOS CA 94022 0 1 0 0 EVP of Corporate Strategy 0 Stock Options 0.75 2023-08-28 4 A 0 1355000 0 A 2033-08-28 Common Stock 1355000 1510000 D 338,750 of the stock options vest on first anniversary of the date of grant and 1/36th of the remaining options vest at the end of each successive month thereafter. /s/ Doug Jermasek 2023-08-30